Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Change in Receivables (2016 - 2025)

Historic Change in Receivables for GeoVax Labs (GOVX) over the last 15 years, with Q3 2025 value amounting to -$532771.0.

  • GeoVax Labs' Change in Receivables fell 31578.67% to -$532771.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$547574.0, marking a year-over-year decrease of 20000.0%. This contributed to the annual value of $659409.0 for FY2024, which is N/A changed from last year.
  • Per GeoVax Labs' latest filing, its Change in Receivables stood at -$532771.0 for Q3 2025, which was down 31578.67% from -$964774.0 recorded in Q2 2025.
  • GeoVax Labs' 5-year Change in Receivables high stood at $838136.0 for Q1 2025, and its period low was -$964774.0 during Q2 2025.
  • Over the past 4 years, GeoVax Labs' median Change in Receivables value was $49763.0 (recorded in 2021), while the average stood at -$18266.3.
  • In the last 5 years, GeoVax Labs' Change in Receivables skyrocketed by 12765.75% in 2022 and then plummeted by 42086.72% in 2025.
  • Over the past 4 years, GeoVax Labs' Change in Receivables (Quarter) stood at $49006.0 in 2021, then plummeted by 303.09% to -$99526.0 in 2022, then skyrocketed by 212.37% to $111835.0 in 2024, then tumbled by 576.39% to -$532771.0 in 2025.
  • Its Change in Receivables was -$532771.0 in Q3 2025, compared to -$964774.0 in Q2 2025 and $838136.0 in Q1 2025.